共 135 条
[1]
Limdi NA(2010)Warfarin pharmacogenetics: Blood 115 3827-3834
[2]
Wadelius M(2009) genotype as predictive as haplotype across three racial groups N. Engl. J. Med. 360 753-764
[3]
Cavallari L(2010)Estimation of warfarin dose using clinical and pharmacogenetic data Pharmacogenet. Genomics 20 407-413
[4]
Eriksson N(2008)Extending and evaluating a warfarin dosing algorithm that includes Clin. Pharmacol. Ther. 84 722-728
[5]
Crawford DC(2011) and pooled rare variants of CYP2C9 Br. J. Clin. Pharmacol. 72 451-453
[6]
Lee MT(2008)Pharmacogenetics of warfarin: development of a dosing algorithm for Brazilian patients Chest 133 160S-198S
[7]
Klein TE(2005)Population diversity and the performance of warfarin dosing algorithms Thromb. Haemost. 94 773-779
[8]
Altman RB(2008)Pharmacology and management of the vitamin K Antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) Pharmacogenomics 9 1237-1250
[9]
Eriksson N(2010) haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation Clin. Pharmacol. Therapeut. 87 459-464
[10]
Gage BF(2008)Effects of Clin. Pharmacol. Therapeut. 84 326-331